Stable CAD (Coronary artery disease)

Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

To further investigate the treatment effects of ticagrelor monotherapy compared with ticagrelor plus aspirin in a contemporary HBR population, a pre-specified analysis of the TWILIGHT trial, TWILIGHT-HBR, was conducted by using the Academic Research Consortium (ARC) criteria for HBR.

Watch this session to discover a selection of cases on stable CAD, stents & scaffolds and learn more about how to cope with complications.

Watch this session to learn more about the benefit/risk trade-off of extended DAPT in "TWILIGHT-like" patients after PCI, as well as the distal transradial access for coronary angiography and interventions.

According to the updated international revascularization guidelines, fractional flow reserve (FFR) and instantaneous wave-free period ratio (iFR) are proposed to dichotomize decision-making for ischemia detection in guiding percutaneous coronary intervention (PCI) of intermediate coronary stenosis.

The objective of the IAMI1 trial was to determine whether early influenza vaccination reduces the risk of cardiovascular events in patients admitted with an acute-MI or high-risk stable coronary artery disease in an adequately powered randomized control trial setting.

A 67-year-old female with a history of recurrent episodes of chest pain presented at the outpatient clinic. She also had a history of hyperlipidaemia, arterial hypertension, peripheral artery disease, diabetes mellitus type 2 and she was an active smoker.

Nicola Ryan presents a synthesis of this study which compares FFR-guided assessment of patients with chest pain with angiographic guidance alone, and which was presented by Nicholas Curzen (Southampton, USA) during the ESC Congress 2021.

Panos Xaplanteris interviews Nick Curzen about this study on FFR-guided assessment of patients with chest pain when compared with angiographic guidance alone which was presented during ESC Congress 2021.